JPWO2020055862A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020055862A5 JPWO2020055862A5 JP2021512665A JP2021512665A JPWO2020055862A5 JP WO2020055862 A5 JPWO2020055862 A5 JP WO2020055862A5 JP 2021512665 A JP2021512665 A JP 2021512665A JP 2021512665 A JP2021512665 A JP 2021512665A JP WO2020055862 A5 JPWO2020055862 A5 JP WO2020055862A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- car
- cells
- ctl
- expressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024118790A JP2024153743A (ja) | 2018-09-10 | 2024-07-24 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862729089P | 2018-09-10 | 2018-09-10 | |
| US62/729,089 | 2018-09-10 | ||
| US201962896707P | 2019-09-06 | 2019-09-06 | |
| US62/896,707 | 2019-09-06 | ||
| PCT/US2019/050404 WO2020055862A1 (en) | 2018-09-10 | 2019-09-10 | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118790A Division JP2024153743A (ja) | 2018-09-10 | 2024-07-24 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021536260A JP2021536260A (ja) | 2021-12-27 |
| JP2021536260A5 JP2021536260A5 (https=) | 2022-09-16 |
| JPWO2020055862A5 true JPWO2020055862A5 (https=) | 2022-09-16 |
| JP7528059B2 JP7528059B2 (ja) | 2024-08-05 |
Family
ID=69778136
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512665A Active JP7528059B2 (ja) | 2018-09-10 | 2019-09-10 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
| JP2024118790A Pending JP2024153743A (ja) | 2018-09-10 | 2024-07-24 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118790A Pending JP2024153743A (ja) | 2018-09-10 | 2024-07-24 | 抗原特異的ｃａｒ－ｔ細胞を拡大増殖する方法、それに関連する組成物及び使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210301255A1 (https=) |
| EP (2) | EP3849571B1 (https=) |
| JP (2) | JP7528059B2 (https=) |
| KR (1) | KR20210061361A (https=) |
| CN (1) | CN112969470A (https=) |
| AU (1) | AU2019338307A1 (https=) |
| BR (1) | BR112021004465A2 (https=) |
| CA (1) | CA3111796A1 (https=) |
| ES (1) | ES3000183T3 (https=) |
| IL (1) | IL281187A (https=) |
| MX (1) | MX2021002702A (https=) |
| SG (1) | SG11202101468XA (https=) |
| WO (1) | WO2020055862A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3000183T3 (en) * | 2018-09-10 | 2025-02-27 | Atara Biotherapeutics Inc | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto |
| SG11202104524YA (en) | 2018-11-01 | 2021-05-28 | Gracell Biotechnologies Shanghai Co Ltd | Compositions and methods for t cell engineering |
| US12590148B2 (en) | 2018-11-26 | 2026-03-31 | Nkarta, Inc. | Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy |
| CN118931967A (zh) * | 2018-12-07 | 2024-11-12 | 亘喜生物科技（上海）有限公司 | 用于免疫疗法的组合物和方法 |
| AU2020232691B2 (en) | 2019-03-05 | 2023-06-29 | Nkarta, Inc. | CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
| WO2022157500A1 (en) * | 2021-01-20 | 2022-07-28 | Coding Bio Limited | Methods for high throughput screening of chimeric antigen receptors |
| EP4381050A4 (en) * | 2021-08-06 | 2025-10-08 | Seattle Childrens Hospital D/B/A Seattle Childrens Res Institute | T CELL MANUFACTURING PROCESSES |
| WO2023159088A1 (en) * | 2022-02-15 | 2023-08-24 | Marker Therapeutics, Inc. | Compositions and methods for antigen-specific t cell expansion |
| WO2023230276A1 (en) * | 2022-05-27 | 2023-11-30 | Kite Pharma, Inc. | Compositions and methods for preparing engineered lymphocytes for cell therapy |
| WO2025076144A1 (en) * | 2023-10-03 | 2025-04-10 | Atara Biotherapeutics, Inc. | Bispecific cd19/cd20-targeted chimeric antigen receptors and uses thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| WO2003057171A2 (en) | 2002-01-03 | 2003-07-17 | The Trustees Of The University Of Pennsylvania | Activation and expansion of t-cells using an engineered multivalent signaling platform |
| US7976845B2 (en) | 2004-11-29 | 2011-07-12 | The Council Of The Queensland Institute Of Medical Research | Human cytomegalovirus immunotherapy |
| CN104769104A (zh) | 2011-12-12 | 2015-07-08 | 细胞药物有限公司 | 扩大t细胞的方法 |
| CA2889064A1 (en) | 2012-10-19 | 2014-04-24 | The Council Of The Queensland Institute Of Medical Research | Improved human herpesvirus immunotherapy |
| CN104462128B (zh) | 2013-09-22 | 2018-04-13 | 腾讯科技（深圳）有限公司 | 多媒体文件处理的方法、装置和终端设备 |
| WO2015154012A1 (en) * | 2014-04-03 | 2015-10-08 | Memorial Sloan-Kettering Cancer Center | Clonogenic natural killer (nk) cell populations and methods of producing and using such populations |
| JP6816031B2 (ja) * | 2015-02-10 | 2021-01-20 | オレゴン ヘルス アンド サイエンス ユニバーシティ | 非標準的なｃｄ８＋ｔ細胞応答を生成するのに有用な方法および組成物 |
| WO2016154628A1 (en) * | 2015-03-26 | 2016-09-29 | Xiuli Wang | Bi-specific targeted chimeric antigen receptor t cells |
| JP7057748B2 (ja) * | 2015-07-16 | 2022-04-20 | イェダ リサーチ アンド ディベロップメント カンパニー リミテッド | 遺伝子改変された抗第三者中枢性メモリーｔ細胞および免疫療法におけるその使用 |
| JP2019520332A (ja) | 2016-05-23 | 2019-07-18 | ザ カウンシル オブ ザ クイーンズランド インスティテュート オブ メディカル リサーチ | Ｃｍｖエピトープ |
| MX2018013959A (es) | 2016-05-25 | 2019-08-22 | Council Queensland Inst Medical Res | Metodos para tratar enfermedad autoinmune usando celulas t alogenicas. |
| KR20240133760A (ko) | 2016-09-09 | 2024-09-04 | 더 카운실 오브 더 퀸즐랜드 인스티튜트 오브 메디컬 리서치 | 폴리오마바이러스에 대한 면역요법 |
| AU2017326173B2 (en) * | 2016-09-16 | 2022-08-18 | Baylor College Of Medicine | Platform for activation and expansion of virus-specific T-cells |
| WO2018075813A1 (en) * | 2016-10-19 | 2018-04-26 | City Of Hope | Use of endogenous viral vaccine in chimeric antigen receptor t cell therapy |
| JP7141725B2 (ja) | 2017-07-07 | 2022-09-26 | エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド | 変異ｃｄ２８共刺激ドメインを有するキメラ抗原受容体 |
| SG11202006050XA (en) | 2017-12-29 | 2020-07-29 | Memorial Sloan Kettering Cancer Center | Enhanced chimeric antigen receptors and uses thereof |
| ES3000183T3 (en) * | 2018-09-10 | 2025-02-27 | Atara Biotherapeutics Inc | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto |
-
2019
- 2019-09-10 ES ES19860431T patent/ES3000183T3/es active Active
- 2019-09-10 CN CN201980073697.6A patent/CN112969470A/zh active Pending
- 2019-09-10 WO PCT/US2019/050404 patent/WO2020055862A1/en not_active Ceased
- 2019-09-10 JP JP2021512665A patent/JP7528059B2/ja active Active
- 2019-09-10 US US17/274,673 patent/US20210301255A1/en active Pending
- 2019-09-10 CA CA3111796A patent/CA3111796A1/en active Pending
- 2019-09-10 BR BR112021004465-5A patent/BR112021004465A2/pt unknown
- 2019-09-10 AU AU2019338307A patent/AU2019338307A1/en active Pending
- 2019-09-10 SG SG11202101468XA patent/SG11202101468XA/en unknown
- 2019-09-10 EP EP19860431.6A patent/EP3849571B1/en active Active
- 2019-09-10 MX MX2021002702A patent/MX2021002702A/es unknown
- 2019-09-10 EP EP24197954.1A patent/EP4458419A3/en active Pending
- 2019-09-10 KR KR1020217010391A patent/KR20210061361A/ko not_active Ceased
-
2021
- 2021-03-02 IL IL281187A patent/IL281187A/en unknown
-
2024
- 2024-07-24 JP JP2024118790A patent/JP2024153743A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021536260A5 (https=) | ||
| JP2019536461A5 (https=) | ||
| Riddell et al. | The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells | |
| JP2019519246A5 (https=) | ||
| CN106074601B (zh) | 用于细胞免疫治疗的方法和组合物 | |
| EP3849571B1 (en) | Methods for expanding antigen-specific car-t cells, compositions and uses related thereto | |
| CN111566201A (zh) | 使用用于表达嵌合抗原受体(car)或转基因t细胞受体(tcr)的病毒载体转导细胞的方法 | |
| Hilders et al. | Isolation and characterization of tumor‐infiltrating lymphocytes from cervical carcinoma | |
| JP2021516256A (ja) | Ｃｄ１９に基づくキメラ抗原受容体及びその利用 | |
| JP2022087340A (ja) | 幹細胞様メモリーｔ細胞の生成および養子免疫療法における使用 | |
| JP2008500052A (ja) | 新規人工抗原提示細胞およびそれらの用途 | |
| JPWO2020055862A5 (https=) | ||
| Jurgens et al. | Transduction of primary lymphocytes with Epstein-Barr virus (EBV) latent membrane protein-specific T-cell receptor induces lysis of virus-infected cells: a novel strategy for the treatment of Hodgkin's disease and nasopharyngeal carcinoma | |
| Foster et al. | Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy | |
| RU2021109354A (ru) | Способы экспандирования антигенспецифических car-t-клеток, композиции и применения, связанные с ними | |
| WO2023125860A1 (zh) | 通用型car-t细胞的制备技术及其应用 | |
| Foster et al. | A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2− donors | |
| Pereira et al. | A case for innate immune effector mechanisms as contributors to disease resistance in SIV-infected sooty mangabeys | |
| CN112279908A (zh) | 识别ebv抗原短肽的t细胞受体及其应用 | |
| CN112251452A (zh) | Til/tcr-t细胞治疗平台 | |
| RU2800920C2 (ru) | Способы экспандирования антигенспецифических car-t-клеток, композиции и применения, связанные с ними | |
| CN120081926A (zh) | 一种识别hla-b1518分子呈递的hpv16 e7的t细胞受体及其应用 | |
| CN117736301A (zh) | 靶向巨细胞病毒pp65的TCR和表达其的T细胞及应用 | |
| WO2023072953A1 (en) | Cell lines for producing a retroviral vector encoding a car | |
| Rooney et al. | Adoptive transfer of polyclonal, EBV-specific cytotoxic T-cell lines for the prevention and treatment of EBV-associated malignancies |